Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL E-PRESCRIBING SOLUTIONS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL E-PRESCRIBING SOLUTIONS MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL E-PRESCRIBING SOLUTIONS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S 5 FORCES MODEL
5.3 STRATEGIC INITIATIVES
6 REGULATORY FRAMWORK
7 GLOBAL E-PRESCRIBING SOLUTIONS MARKET, BY TYPE
7.1 OVERVIEW
7.2 SOLUTIONS
7.2.1 STAND-ALONE SOLUTION
7.2.1.1. HANDHELD DEVICES
7.2.1.1.1. CONTROLLED SUBSTANCES
7.2.1.1.1.1 MARKET VALUE (USD MN)
7.2.1.1.1.2 MARKET VOLUME (UNITS)
7.2.1.1.1.3 AVERAGE SELLING PRICE (USD)
7.2.1.1.2. NON-CONTROLLED SUBSTANCES
7.2.1.1.2.1 MARKET VALUE (USD MN)
7.2.1.1.2.2 MARKET VOLUME (UNITS)
7.2.1.1.2.3 AVERAGE SELLING PRICE (USD)
7.2.1.1.3. COMPUTER BASED DEVICES
7.2.1.1.3.1 CONTROLLED SUBSTANCES
7.2.1.1.3.1.1. MARKET VALUE (USD MN)
7.2.1.1.3.1.2. MARKET VOLUME (UNITS)
7.2.1.1.3.1.3. AVERAGE SELLING PRICE (USD)
7.2.1.1.3.2 NON-CONTROLLED SUBSTANCES
7.2.1.1.3.2.1. MARKET VALUE (USD MN)
7.2.1.1.3.2.2. MARKET VOLUME (UNITS)
7.2.1.1.3.2.3. AVERAGE SELLING PRICE (USD)
7.2.2 INTEGRATED SOLUTION
7.2.2.1. HANDHELD DEVICES
7.2.2.1.1. CONTROLLED SUBSTANCES
7.2.2.1.1.1 MARKET VALUE (USD MN)
7.2.2.1.1.2 MARKET VOLUME (UNITS)
7.2.2.1.1.3 AVERAGE SELLING PRICE (USD)
7.2.2.1.2. NON-CONTROLLED SUBSTANCES
7.2.2.1.2.1 MARKET VALUE (USD MN)
7.2.2.1.2.2 MARKET VOLUME (UNITS)
7.2.2.1.2.3 AVERAGE SELLING PRICE (USD)
7.2.2.2. COMPUTER BASED DEVICES
7.2.2.2.1. CONTROLLED SUBSTANCES
7.2.2.2.1.1 MARKET VALUE (USD MN)
7.2.2.2.1.2 MARKET VOLUME (UNITS)
7.2.2.2.1.3 AVERAGE SELLING PRICE (USD)
7.2.2.2.2. NON-CONTROLLED SUBSTANCES
7.2.2.2.2.1 MARKET VALUE (USD MN)
7.2.2.2.2.2 MARKET VOLUME (UNITS)
7.2.2.2.2.3 AVERAGE SELLING PRICE (USD)
7.3 SERVICES
7.3.1 SUPPORT & MAINTENANCE SERVICES
7.3.1.1. CONTROLLED SUBSTANCES
7.3.1.2. NON-CONTROLLED SUBSTANCES
7.3.2 IMPLEMENTATION SERVICES
7.3.2.1. CONTROLLED SUBSTANCES
7.3.2.2. NON-CONTROLLED SUBSTANCES
7.3.3 NETWORK SERVICES
7.3.3.1. CONTROLLED SUBSTANCES
7.3.3.2. NON-CONTROLLED SUBSTANCES
7.3.4 TRAINING AND EDUCATION SERVICES
7.3.4.1. CONTROLLED SUBSTANCES
7.3.4.2. NON-CONTROLLED SUBSTANCES
8 GLOBAL E-PRESCRIBING SOLUTIONS MARKET, BY DEPLOYMENT TYPE
8.1 OVERVIEW
8.2 WEB/CLOUD BASED
8.3 ON-PREMISES
9 GLOBAL E-PRESCRIBING SOLUTIONS MARKET, BY SPECIALTY
9.1 OVERVIEW
9.2 ONCOLOGY
9.2.1 SOLUTIONS
9.2.1.1. STAND-ALONE SOLUTION
9.2.1.2. INTEGRATED SOLUTION
9.2.2 SERVICES
9.2.2.1. SUPPORT & MAINTENANCE SERVICES
9.2.2.2. IMPLEMENTATION SERVICES
9.2.2.3. NETWORK SERVICES
9.2.2.4. TRAINING AND EDUCATION SERVICES
9.3 SPORTS MEDICINE
9.3.1 SOLUTIONS
9.3.1.1. STAND-ALONE SOLUTION
9.3.1.2. INTEGRATED SOLUTION
9.3.2 SERVICES
9.3.2.1. SUPPORT & MAINTENANCE SERVICES
9.3.2.2. IMPLEMENTATION SERVICES
9.3.2.3. NETWORK SERVICES
9.3.2.4. TRAINING AND EDUCATION SERVICES
9.4 NEUROLOGY
9.4.1 SOLUTIONS
9.4.1.1. STAND-ALONE SOLUTION
9.4.1.2. INTEGRATED SOLUTION
9.4.2 SERVICES
9.4.2.1. SUPPORT & MAINTENANCE SERVICES
9.4.2.2. IMPLEMENTATION SERVICES
9.4.2.3. NETWORK SERVICES
9.4.2.4. TRAINING AND EDUCATION SERVICES
9.5 CARDIOLOGY
9.5.1 SOLUTIONS
9.5.1.1. STAND-ALONE SOLUTION
9.5.1.2. INTEGRATED SOLUTION
9.5.2 SERVICES
9.5.2.1. SUPPORT & MAINTENANCE SERVICES
9.5.2.2. IMPLEMENTATION SERVICES
9.5.2.3. NETWORK SERVICES
9.5.2.4. TRAINING AND EDUCATION SERVICES
9.6 RESPIRATORY
9.6.1 SOLUTIONS
9.6.1.1. STAND-ALONE SOLUTION
9.6.1.2. INTEGRATED SOLUTION
9.6.2 SERVICES
9.6.2.1. SUPPORT & MAINTENANCE SERVICES
9.6.2.2. IMPLEMENTATION SERVICES
9.6.2.3. NETWORK SERVICES
9.6.2.4. TRAINING AND EDUCATION SERVICES
9.7 MUSCULOSKELETAL
9.7.1 SOLUTIONS
9.7.1.1. STAND-ALONE SOLUTION
9.7.1.2. INTEGRATED SOLUTION
9.7.2 SERVICES
9.7.2.1. SUPPORT & MAINTENANCE SERVICES
9.7.2.2. IMPLEMENTATION SERVICES
9.7.2.3. NETWORK SERVICES
9.7.2.4. TRAINING AND EDUCATION SERVICES
9.8 OBSTETRICS AND GYNAECOLOGY
9.8.1 SOLUTIONS
9.8.1.1. STAND-ALONE SOLUTION
9.8.1.2. INTEGRATED SOLUTION
9.8.2 SERVICES
9.8.2.1. SUPPORT & MAINTENANCE SERVICES
9.8.2.2. IMPLEMENTATION SERVICES
9.8.2.3. NETWORK SERVICES
9.8.2.4. TRAINING AND EDUCATION SERVICES
9.9 ORTHOPAEDIC
9.9.1 SOLUTIONS
9.9.1.1. STAND-ALONE SOLUTION
9.9.2 INTEGRATED SOLUTION
9.9.3 SERVICES
9.9.3.1. SUPPORT & MAINTENANCE SERVICES
9.9.3.2. IMPLEMENTATION SERVICES
9.9.3.3. NETWORK SERVICES
9.9.3.4. TRAINING AND EDUCATION SERVICES
9.9.4 SOLUTIONS
9.9.4.1. STAND-ALONE SOLUTION
9.9.4.2. INTEGRATED SOLUTION
9.9.5 SERVICES
9.9.5.1. SUPPORT & MAINTENANCE SERVICES
9.9.5.2. IMPLEMENTATION SERVICES
9.9.5.3. NETWORK SERVICES
9.9.5.4. TRAINING AND EDUCATION SERVICES
9.1 PSYCHIATRIC
9.10.1 SOLUTIONS
9.10.1.1. STAND-ALONE SOLUTION
9.10.1.2. INTEGRATED SOLUTION
9.10.2 SERVICES
9.10.2.1. SUPPORT & MAINTENANCE SERVICES
9.10.2.2. IMPLEMENTATION SERVICES
9.10.2.3. NETWORK SERVICES
9.10.2.4. TRAINING AND EDUCATION SERVICES
9.11 OTHERS
10 GLOBAL E-PRESCRIBING SOLUTIONS MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS & HEALTH SYSTEMS
10.3 SPECIALTY CARE
10.4 INDEPENDENT & SPECIALTY PHARMACIES
10.5 PHARMACY BENEFIT MANAGERS (PBM) AND PAYORS
10.6 TELEHEALTH & PHARMACY SOFTWARE VENDORS
10.7 OTHERS
11 GLOBAL E-PRESCRIBING SOLUTIONS MARKET, BY REGION
11.1 GLOBAL E-PRESCRIBING SOLUTIONS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
11.2 NORTH AMERICA
11.2.1 U.S.
11.2.1.1. U.S. E-PRESCRIBING SOLUTIONS MARKET, BY TYPE
11.2.1.2. U.S. E-PRESCRIBING SOLUTIONS MARKET, BY DEPLOYMENT TYPE
11.2.1.3. U.S. E-PRESCRIBING SOLUTIONS MARKET, BY SPECIALTY
11.2.1.4. U.S. E-PRESCRIBING SOLUTIONS MARKET, BY END USER
11.2.2 CANADA
11.2.3 MEXICO
11.3 EUROPE
11.3.1 GERMANY
11.3.2 FRANCE
11.3.3 U.K.
11.3.4 ITALY
11.3.5 SPAIN
11.3.6 RUSSIA
11.3.7 TURKEY
11.3.8 BELGIUM
11.3.9 NETHERLANDS
11.3.10 SWITZERLAND
11.3.11 REST OF EUROPE
11.4 ASIA-PACIFIC
11.4.1 JAPAN
11.4.2 CHINA
11.4.3 SOUTH KOREA
11.4.4 INDIA
11.4.5 AUSTRALIA
11.4.6 SINGAPORE
11.4.7 THAILAND
11.4.8 MALAYSIA
11.4.9 INDONESIA
11.4.10 PHILIPPINES
11.4.11 REST OF ASIA-PACIFIC
11.5 SOUTH AMERICA
11.5.1 BRAZIL
11.5.2 ARGENTINA
11.5.3 REST OF SOUTH AMERICA
11.6 MIDDLE EAST AND AFRICA
11.6.1 SOUTH AFRICA
11.6.2 SAUDI ARABIA
11.6.3 UAE
11.6.4 EGYPT
11.6.5 ISRAEL
11.6.6 REST OF MIDDLE EAST AND AFRICA
11.7 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
12 GLOBAL E-PRESCRIBING SOLUTIONS MARKET, SWOT AND DBMR ANALYSIS
13 GLOBAL E-PRESCRIBING SOLUTIONS MARKET, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: GLOBAL
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
13.3 COMPANY SHARE ANALYSIS: EUROPE
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
13.5 MERGERS & ACQUISITIONS
13.6 NEW PRODUCT DEVELOPMENT & APPROVALS
13.7 EXPANSIONS
13.8 REGULATORY CHANGES
13.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
14 GLOBAL E-PRESCRIBING SOLUTIONS MARKET, COMPANY PROFILE
14.1 EPIC SYSTEMS CORPORATION
14.1.1 COMPANY OVERVIEW
14.1.2 REVENUE ANALYSIS
14.1.3 GEOGRAPHIC PRESENCE
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 CERNER CORPORATION
14.2.1 COMPANY OVERVIEW
14.2.2 REVENUE ANALYSIS
14.2.3 GEOGRAPHIC PRESENCE
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
14.3.1 COMPANY OVERVIEW
14.3.2 REVENUE ANALYSIS
14.3.3 GEOGRAPHIC PRESENCE
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 NEXTGEN HEALTHCARE
14.4.1 COMPANY OVERVIEW
14.4.2 REVENUE ANALYSIS
14.4.3 GEOGRAPHIC PRESENCE
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 ATHENAHEALTH, INC.
14.5.1 COMPANY OVERVIEW
14.5.2 REVENUE ANALYSIS
14.5.3 GEOGRAPHIC PRESENCE
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 GE HEALTHCARE
14.6.1 COMPANY OVERVIEW
14.6.2 REVENUE ANALYSIS
14.6.3 GEOGRAPHIC PRESENCE
14.6.4 PRODUCT PORTFOLIO
14.6.5 RECENT DEVELOPMENTS
14.7 DRFIRST, INC.
14.7.1 COMPANY OVERVIEW
14.7.2 REVENUE ANALYSIS
14.7.3 GEOGRAPHIC PRESENCE
14.7.4 PRODUCT PORTFOLIO
14.7.5 RECENT DEVELOPMENTS
14.8 SURESCRIPTS-RXHUB, LLC
14.8.1 COMPANY OVERVIEW
14.8.2 REVENUE ANALYSIS
14.8.3 GEOGRAPHIC PRESENCE
14.8.4 PRODUCT PORTFOLIO
14.8.5 RECENT DEVELOPMENTS
14.9 MEDICAL INFORMATION TECHNOLOGY, INC.
14.9.1 COMPANY OVERVIEW
14.9.2 REVENUE ANALYSIS
14.9.3 GEOGRAPHIC PRESENCE
14.9.4 PRODUCT PORTFOLIO
14.9.5 RECENT DEVELOPMENTS
14.1 HENRY SCHEIN INC.
14.10.1 COMPANY OVERVIEW
14.10.2 REVENUE ANALYSIS
14.10.3 GEOGRAPHIC PRESENCE
14.10.4 PRODUCT PORTFOLIO
14.10.5 RECENT DEVELOPMENTS
14.11 INSYNC HEALTHCARE SOLUTIONS
14.11.1 COMPANY OVERVIEW
14.11.2 REVENUE ANALYSIS
14.11.3 GEOGRAPHIC PRESENCE
14.11.4 PRODUCT PORTFOLIO
14.11.5 RECENT DEVELOPMENTS
14.12 PRACTICE FUSION INC.
14.12.1 COMPANY OVERVIEW
14.12.2 REVENUE ANALYSIS
14.12.3 GEOGRAPHIC PRESENCE
14.12.4 PRODUCT PORTFOLIO
14.12.5 RECENT DEVELOPMENTS
14.13 ADVANCEDMD
14.13.1 COMPANY OVERVIEW
14.13.2 REVENUE ANALYSIS
14.13.3 GEOGRAPHIC PRESENCE
14.13.4 PRODUCT PORTFOLIO
14.13.5 RECENT DEVELOPMENTS
14.14 AEGIS HEALTHCARE
14.14.1 COMPANY OVERVIEW
14.14.2 REVENUE ANALYSIS
14.14.3 GEOGRAPHIC PRESENCE
14.14.4 PRODUCT PORTFOLIO
14.14.5 RECENT DEVELOPMENTS
14.15 BIZMATICS
14.15.1 COMPANY OVERVIEW
14.15.2 REVENUE ANALYSIS
14.15.3 GEOGRAPHIC PRESENCE
14.15.4 PRODUCT PORTFOLIO
14.15.5 RECENT DEVELOPMENTS
14.16 BRAVADO HEALTH
14.16.1 COMPANY OVERVIEW
14.16.2 REVENUE ANALYSIS
14.16.3 GEOGRAPHIC PRESENCE
14.16.4 PRODUCT PORTFOLIO
14.16.5 RECENT DEVELOPMENTS
14.17 CARECLOUD
14.17.1 COMPANY OVERVIEW
14.17.2 REVENUE ANALYSIS
14.17.3 GEOGRAPHIC PRESENCE
14.17.4 PRODUCT PORTFOLIO
14.17.5 RECENT DEVELOPMENTS
14.18 CHANGE HEALTHCARE
14.18.1 COMPANY OVERVIEW
14.18.2 REVENUE ANALYSIS
14.18.3 GEOGRAPHIC PRESENCE
14.18.4 PRODUCT PORTFOLIO
14.18.5 RECENT DEVELOPMENTS
14.19 CHETU
14.19.1 COMPANY OVERVIEW
14.19.2 REVENUE ANALYSIS
14.19.3 GEOGRAPHIC PRESENCE
14.19.4 PRODUCT PORTFOLIO
14.19.5 RECENT DEVELOPMENTS
14.2 CREDIBLE
14.20.1 COMPANY OVERVIEW
14.20.2 REVENUE ANALYSIS
14.20.3 GEOGRAPHIC PRESENCE
14.20.4 PRODUCT PORTFOLIO
14.20.5 RECENT DEVELOPMENTS
14.21 DAW SYSTEMS
14.21.1 COMPANY OVERVIEW
14.21.2 REVENUE ANALYSIS
14.21.3 GEOGRAPHIC PRESENCE
14.21.4 PRODUCT PORTFOLIO
14.21.5 RECENT DEVELOPMENTS
14.22 PRN SOFTWARE, LLC.
14.22.1 COMPANY OVERVIEW
14.22.2 REVENUE ANALYSIS
14.22.3 GEOGRAPHIC PRESENCE
14.22.4 PRODUCT PORTFOLIO
14.22.5 RECENT DEVELOPMENTS
14.23 DR. CHRONO
14.23.1 COMPANY OVERVIEW
14.23.2 REVENUE ANALYSIS
14.23.3 GEOGRAPHIC PRESENCE
14.23.4 PRODUCT PORTFOLIO
14.23.5 RECENT DEVELOPMENTS
14.24 EMDS
14.24.1 COMPANY OVERVIEW
14.24.2 REVENUE ANALYSIS
14.24.3 GEOGRAPHIC PRESENCE
14.24.4 PRODUCT PORTFOLIO
14.24.5 RECENT DEVELOPMENTS
14.25 KAREO, INC.
14.25.1 COMPANY OVERVIEW
14.25.2 REVENUE ANALYSIS
14.25.3 GEOGRAPHIC PRESENCE
14.25.4 PRODUCT PORTFOLIO
14.25.5 RECENT DEVELOPMENTS
14.26 MD TOOLBOX
14.26.1 COMPANY OVERVIEW
14.26.2 REVENUE ANALYSIS
14.26.3 GEOGRAPHIC PRESENCE
14.26.4 PRODUCT PORTFOLIO
14.26.5 RECENT DEVELOPMENTS
14.27 RXNT
14.27.1 COMPANY OVERVIEW
14.27.2 REVENUE ANALYSIS
14.27.3 GEOGRAPHIC PRESENCE
14.27.4 PRODUCT PORTFOLIO
14.27.5 RECENT DEVELOPMENTS
14.28 SISGAIN
14.28.1 COMPANY OVERVIEW
14.28.2 REVENUE ANALYSIS
14.28.3 GEOGRAPHIC PRESENCE
14.28.4 PRODUCT PORTFOLIO
14.28.5 RECENT DEVELOPMENTS
14.29 STREAMLINE HEALTHCARE SOLUTIONS
14.29.1 COMPANY OVERVIEW
14.29.2 REVENUE ANALYSIS
14.29.3 GEOGRAPHIC PRESENCE
14.29.4 PRODUCT PORTFOLIO
14.29.5 RECENT DEVELOPMENTS
14.3 TENELEVEN GROUP
14.30.1 COMPANY OVERVIEW
14.30.2 REVENUE ANALYSIS
14.30.3 GEOGRAPHIC PRESENCE
14.30.4 PRODUCT PORTFOLIO
14.30.5 RECENT DEVELOPMENTS
14.31 NEWCROP, LLC
14.31.1 COMPANY OVERVIEW
14.31.2 REVENUE ANALYSIS
14.31.3 GEOGRAPHIC PRESENCE
14.31.4 PRODUCT PORTFOLIO
14.31.5 RECENT DEVELOPMENTS
*NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
15 RELATED REPORTS
16 CONCLUSION
17 QUESTIONNAIRE
18 ABOUT DATA BRIDGE MARKET RESEARCH
